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Abstract

Introduction Approximately 35% of patients with cancer
experience clinically significant distress, and unmet
psychological supportive care needs are prevalent. This
study describes the protocol for a randomised controlled
trial (RCT) to assess the efficacy and cost-effectiveness of
an internet-based psychological intervention for distressed
patients with cancer.
Methods and analysis In phase I, the intervention was
developed on an interactive web platform and pilot tested for
acceptability using a qualitative methodology with 21 patients
with cancer. Phase II is an RCT underway with patients with
or at risk of elevated psychological distress comparing: (1)
static patient education website with (2) individualised webdelivered cognitive behavioural intervention (CancerCope).
Participants were recruited through the Queensland Cancer
Registry and Cancer Council Helpline and met the following
inclusion criteria: (1) recently diagnosed with cancer; (2) able
to read and speak English; (3) no previous history of head
injury, dementia or psychiatric illness; (4) no other concurrent
cancer; (5) phone and internet access; (5) scored ≥4 on the
Distress Thermometer. Participants are assessed at four
time points: baseline/recruitment and 2, 6 and 12 months
after recruitment and intervention commencement. Of the
163 participants recruited, 50% met caseness for distress.
The area of highest unmet supportive care needs were
psychological followed by physical and daily living needs.
Primary outcomes are psychological and cancer-specific
distress and unmet psychological supportive care needs.
Secondary outcomes are positive adjustment, quality of life
and cost-effectiveness.
Ethics and dissemination Ethical approval was obtained
from the Griffith University Human Research Ethics
Committee (Approval: PSY/70/13/HREC) and the Metro
South Human Research Ethics Committee (HREC/13/
QPAH/601). All participants provide informed consent prior
to taking part in the study. Once completed, this study will
provide recommendations about the efficacy of web-based
cognitive behavioural interventions to facilitate better
psychosocial adjustment for people with cancer.
Trial registration number ANZCTR
(ACTRN12613001026718).

Introduction
In Australia in 2014, approximately 123 900
new cases of cancer were diagnosed, and in

Strengths and limitations of this study
►► This study will be conducted as a randomised

controlled trial testing a web-based psychological
intervention to assist distressed patients with
cancer.
►► Patients with melanoma and colorectal cancer were
specifically targeted, and there is a gap in knowledge
about effective psychosocial interventions for these
patients.
►► The use of the web-based delivery method means
that should the intervention prove effective, it can be
disseminated on a population level at very low cost.
►► Web-based interventions rely on the patient having
ready access to the internet and sufficient web
literacy to use the programme.

2009, over 370 000 Australians were within 5
years of a diagnosis of cancer.1 The majority
of people diagnosed with cancer adjust well
over time; however, around 35% of cancer
survivors experience clinically important
psychological distress that may persist or even
intensify over time,2 3 with an increased risk of
suicide in the first 12 months after diagnosis4
and for people with advanced cancer.5 6
Psychosocial care is now well recognised
as an integral part of best practice oncology
care, and various groups in North America
and Australia have developed clinical practice
guidelines providing recommendations for
such care.7–9 However, despite this, the provision of evidence-based psychosocial care for
patients with cancer is far from universal.10 11
In Australia, unmet psychological supportive
care needs in patients with cancer are highly
prevalent, with up to 89% of people with
cancer reporting unmet need.12 For example,
in one study of Australian breast cancer survivors, approximately one-quarter of women
had unmet needs for help with cancer
recurrence and stress; and clinically anxious
survivors reported over three times as many
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unmet needs as those who were not anxious.13 14 Psychosocial care services accessible across the illness experience
are urgently needed and these will need to be community-based if they are to be accessible beyond the acute
treatment setting.
Community-based approaches to psychosocial intervention
Community-based organisations are important providers
of support services for patients with cancer, many of
whom provide tele-based information services or helplines as a front line.15 16 The Helpline service in Australia
is conducted by state Cancer Councils in each jurisdiction staffed by nurses and allied health professionals who
have experience and/or qualifications in oncology and
additional training in psychosocial support.17 However,
helplines are relatively staff/resource intensive and so
have limited capacity to meet the needs of the cancer
population into the future and provide brief emotional
support and patient education rather than directed
psychological therapies. As the cancer burden increases,
unless an intervention approach is developed that can be
scaled to population level, there is little hope that existing
health services will meet psychosocial care needs for this
target group.
A web-based approach may provide an answer. The
internet overcomes many of the barriers associated with
traditional face-to-face therapy,18 19 such as the need to
travel to receive therapy and the inconvenience of scheduling appointments. Internet-based interventions may
also reduce the total time of treatment, as patients would
not have to delay treatment while waiting for specialty
clinic appointments, but could instead start and proceed
through the intervention at the recommended pace.
This approach also promotes self-management, whereby

individuals monitor their condition and use the appropriate steps to achieve a satisfactory quality of life (QoL).20
Self-management interventions can improve mood across
a range of chronic illnesses20 and for patients with cancer
with subthreshold depression that have been found to
lower the later incidence of major depression.21 Therefore, interventions based on self-management have great
potential as cost-effective psychological care, as well as the
advantages of equity, choice and accessibility.22
Accordingly, we proposed a web-based self-help intervention to assist people experiencing distress after a
cancer diagnosis. In phase I, the intervention was developed on an interactive web platform and pilot tested for
acceptability. Phase II now underway is a randomised
controlled trial (RCT) with patients with cancer who
either have or are at risk of having elevated psychological
distress and will compare: (1) a static patient education
website and (2) an individualised web-delivered cognitive behavioural intervention (CancerCope). This paper
reports the development of the trial protocol, study
implementation and sociodemographic and clinical characteristics of participants, including psychological and
cancer-specific distress, unmet supportive care needs and
QoL.
Methods and analysis
Phase I
The CancerCope programme was developed based on
a five-session telephone-based cognitive behavioural
therapy intervention23 24 and modified with six cores
covering: stress reduction, problem solving, cognitive
challenging and improving well-being. The cores consist
of educational information and expert videos from

Table 1 Overview of core components in CancerCope intervention
Core

Objectives

 Core 1—The Cancer Journey

►►Recognise and understand reactions to cancer diagnosis.
►►Learn about relaxation exercise, how to do it and how it can help to cope with stressful
situations.
►►Learn about the body’s natural response to threat or change.
►►Recognise early warning signs of stress in the body.
►►Learn about different relaxation techniques.

 Core 2—Understanding Stress

 Core 3—Managing Worry

►►Learn to identify, and better manage, unhelpful thoughts.
►►Learn how to open up to difficult thoughts and feelings.
►►Understand mindfulness and how it can help to manage worry.
►►Learn how to practice mindfulness.

 Core 4—Tackling Problems

►►Learn steps for successful problem solving.
►►Learn tips to guide making difficult decisions.

 Core 5—Taking Care

►►Be reminded of the importance of looking after well-being.
►►Learn about the potential benefits of exercise and healthy eating.
►►Learn tips for improving sleep.
►►Learn ways to manage fatigue.
►►Make plans for coping with future challenges.
►►Identify values and goals for the future.

 Core 6—Moving Forward

2
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psychologists, as well as stories and videos about four
fictional characters on their cancer journey to illustrate
the different experiences of others (see table 1).
The programme has high levels of interactivity including
quizzes, online diaries and games to increase user engagement, and systems to encourage use and self-management
including personalised email reminders, follow-up and
feedback. Cancer Council Queensland (CCQ) counsellors
are alerted if a user is distressed or at high risk of distress
(based on data input), triggering the need for contact.
Content is tailored to the user’s needs as determined by
their input, including assigned behavioural homework
supported by interactive components. Components that
target challenges associated with cancer treatments (eg,
pain, sleep disturbance, fatigue) are additionally selected
if relevant. Cores are completed weekly over a 6-week
period with ongoing access to the programme for 12
months.
The CancerCope programme was pilot-tested with 21
high-distress patients with cancer recruited from the CCQ
Cancer Helpline, a telephone information and support
service in which callers are routinely screened for distress
using the Distress Thermometer (DT)9 , in October–
November 2014, with 2-month follow-up being completed
early February 2015. Callers indicate on a scale of 0 to 10
how much distress they have been experiencing in the
past week including the current day. Higher scores indicate greater distress. Inclusion criteria for phase I were
that participants must: (1) be recently diagnosed with
cancer; (2) be able to read and speak English; (3) have no
previous history of head injury, dementia or psychiatric
illness; (4) have no other concurrent cancer and (5) have
phone and internet access.
Callers to the Cancer Helpline who met the selection
criteria and who scored ≥4 on the DT9 were offered entry
into the study by the operator at the time of the call. Once
verbal permission to be contacted was obtained, the operator provided the Research Team with participant contact
details. Callers were then contacted by the project staff to
complete recruitment and organise access to the CancerCope programme. For phase I, access to the programme
was provided for 6 weeks. Baseline assessments were
conducted via telephone at the time of recruitment and
via online at 2 months postrecruitment. Baseline and
follow-up assessments contained the same measures as
in phase II (as detailed in the Measures section under
Phase II). Semistructured interviews were conducted at
the 2-month assessment point to improve understanding
of the nature of the intervention, assess specific components/tools delivered and the mechanisms of change and
provide an in-depth analysis of patients’ responses to the
intervention. These interviews were audiotaped, transcribed verbatim and analysed using thematic analysis.
Of the 21 participants recruited for phase I, 18 were
women and 3 were men, with an average age of 56 years
(range 39–73 years). The most common cancer types were
breast (8), lung (3) and prostate (3), with other cancer
types including endometrial, lymphoma, ovarian, rectal
Chambers SK, et al. BMJ Open 2017;7:e017279. doi:10.1136/bmjopen-2017-017279

and renal cancer. Sixteen of the 21 participants accessed
the intervention. All 21 participants completed baseline
assessment, with 17 participants completing the 2-month
follow-up assessment. A total of 57.6% participants met
caseness on the Brief Symptom Inventory 18 (BSI 18)
for clinically significant psychological distress (as indicated by a score of ≥57 for either total Global Severity
Index (GSI) t-score or two subscale t-scores)25 at baseline,
compared with 58.8% at 2 months.
The qualitative interviews at 2 months indicated that
participants found the relaxation components, personal
stories and psychologist videos helpful, and the site easy
to use.
“I was having, you know, anxiety and stuff and it was
just, the relaxation stuff was helping me with it…just
listening to other people, what they go through and
just realising that you’re not alone…”
“I liked watching the videos and hearing from
people.”
“Easy to get into and understandable.”
“I thought it [CancerCope] was quite informative, it
was factual, and at least I felt like it was coming from
a reliable source.”
Reasons given for not using the programme included
being too unwell/busy with treatment, and already had
enough support.
“A lot of days I just felt sick, either sick or tired and
that wasn’t one of the things I thought of fitting in the
day I guess.”.
“I was worried about my treatment, that was the main
thing on my mind…Now I’m – now I’m into my
treatment I think I’m more able…it (CancerCope)
has been on my mind, I must go back and do that,
but yeah, I’ve just kept putting it on the backburner.”
“I’ve had so much on, I’ve been in hospital…Yeah,
look, I’m coping, I’m coping fantastic. I’ve got heaps
of support from my church and from my friends.”
Suggestions for change included less reading and making
it more specific to other cancers.
“There’s lots of reading to do though…and for me
now…I’m just ready to move on.”
“There’s so many different cancers out there, maybe
customise the program for the type of cancer each
person has…I think people…could lose interest
because…a lot of the study might not relate to you.”
Based on the pilot, content in the CancerCope programme
was reduced and simplified where possible, and some text
converted to a video format.
Phase II
For the trial phase of the project, it is hypothesised that 2,
6 and 12 months after recruitment and commencement
of the intervention:
3
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1. Relative to participants receiving patient education,
participants receiving CancerCope will report
significantly less anxiety and depression, less cancerspecific distress, lower unmet psychological supportive
care needs, higher positive adjustment and improved
QoL.
2. That from a health sector perspective, the incremental
cost–utility ratio from CancerCope will be compared
with a threshold of $50 000 per quality-adjusted lifeyear (QALY) to evaluate the effectiveness of the
intervention for patients who have, or are at risk of,
elevated psychological distress.
Group condition
Patient education
Access to a static website containing information that
covers stress management skills, problem-solving
approaches to cancer-related concerns and patient
education about a healthy lifestyle to promote wellness
and optimise QoL.
Individualised web-delivered cognitive behavioural intervention
Structured internet delivery of an individualised cognitive behavioural intervention as described previously.
Participants
Recruitment was undertaken through: (1) the Queensland
Cancer Registry (QCR), a population-based register
of cancer diagnoses in Queensland, and (2) the CCQ
Cancer Helpline, a telephone information and support
service in which callers are routinely screened for distress.
For recruitment through the QCR, clinicians were
approached for permission to contact their patients
about the study. Where the doctor had given permission
for contact, those patients are contacted for consent.
Informed written consent was obtained before study
commencement and data collection. For recruitment
through the Cancer Helpline, callers who met selection
criteria were offered entry into the study by the Helpline operator at the time of the call and were contacted
by project staff for consent to be in the study (see
figure 1).
Inclusion criteria for QCR recruitment were that
participants must: (1) have been recently diagnosed with
melanoma or colorectal cancer (patients will be within
6 months postdiagnosis at recruitment); (2) be able to
read and speak English; (3) have no previous history of
head injury, dementia or psychiatric illness; (4) have no
other concurrent cancer; (5) have phone and internet
access; and (6) have physician clearance to participate
in the study. The diagnosing clinician assisted in determining eligibility as part of the consent process through
the QCR described above. Patients were screened for
distress using the DT9 during the recruitment process and
those patients who scored ≥4 (indicating high distress or
risk of high distress) were eligible.
Eligible individuals recruited through the Cancer Helpline were all adult callers who had been diagnosed with
4

cancer, scored ≥4 on the DT9 and met inclusion criteria
2 to 5 above.
Study integrity
Ethical approval was obtained from the Griffith University Human Research Ethics Committee (Approval:
PSY/70/13/HREC) and the Metro South Human
Research Ethics Committee (HREC/13/QPAH/601).
The study design was guided by the CONSORT statement.26 Randomisation occurred following baseline
assessment. Project staff tracking assessments were
blinded to condition. Randomisation occurred in blocks
of 10, with each condition randomly generated five times
within each block to ensure an unpredictable allocation
sequence with equal numbers of participants in each
group at the completion of each block. This sequence was
undertaken by the project manager and concealed from
investigators. All analyses will be conducted on the basis
of intention to treat. As the web-based intervention is fully
standardised, there are no variations from user to user,
except with regards to completion of all components
which is recorded and will be included in analyses.
Measures
A series of previously validated and reliable self-report
measures are administered at four time points: baseline/
recruitment and at 2, 6 and 12 months after recruitment
and intervention commencement. Baseline assessments
are conducted by telephone prior to randomisation,
and include background variables and economic analysis information. Follow-up assessments are conducted
through online questionnaires accessed through the web
support programme. Data are stored securely on project
databases and only accessible to research personnel
trained in confidentiality and privacy procedures.
As is standard practice for eHealth interventions, participants are unable to access the CancerCope programme
while their assessment is due. Participants are notified
by email that their follow-up assessment is due and that,
once their questionnaire is completed, they can continue
on in the CancerCope programme. They are also advised
of CCQ supportive care services available to them, and
that they can contact the Project Manager should they
need support.
If after 3 days the follow-up assessment has not been
completed, an email reminder is sent to the participant. If after 7 days the follow-up assessment has not
been completed, the participant receives a follow-up call
reminding them to complete their online assessment.
The participant regains access to the intervention immediately after this phone call regardless of assessment
completion. Ten attempts are made to contact the participant, after which the assessment is marked as missed and
the participant regains access to the intervention.
Primary outcomes are psychological and cancer-specific distress and unmet supportive care needs. Secondary
outcomes are positive adjustment and QoL and health
economics. Process measures are also included for the
Chambers SK, et al. BMJ Open 2017;7:e017279. doi:10.1136/bmjopen-2017-017279
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Figure 1

Flow chart of recruitment and intervention for phase II.

intervention arm. For participants recruited through
the QCR, disease variables (eg, cancer grade, stage) are
assessed through cancer registry records.
Background variables
Background variables include sociodemographic and
disease variables (eg, cancer site and stage, medical treatments received, use of alternative therapies). We also
assess previous (past month) and current use of support
services and reassess use of such services at subsequent
self-report assessments. This will allow us to control for
any background effects in our analyses and contribute
data to the economic analysis.
Chambers SK, et al. BMJ Open 2017;7:e017279. doi:10.1136/bmjopen-2017-017279

Primary outcomes
Psychological distress: The BSI 1827 assessed psychological
distress through three subscales of depression, anxiety
and somatisation, and also yields an overall distress score,
the GSI. Higher scores indicate higher psychological
distress.
Cancer-specific distress: The Impact of Event Scale
(IES)28 29 assessed cancer-specific distress. The IES has
two subscales that measure the extent to which participants are experiencing intrusive thoughts about cancer
and avoiding thinking about cancer. Epping-Jordan et al30
suggest that intrusion and avoidance are more sensitive
5
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measures of psychological distress after a cancer diagnosis than generalised distress measures. Higher scores
indicate higher cancer-specific distress.
Unmet supportive care needs: The Supportive Care
Needs Survey Short Form 34 is a 34-item survey assessing
the need for help for patients with cancer over the last
month across five domains: psychological, health systems
and information, patient care and support, physical and
daily living and sexuality needs. Higher scores reflect
higher support needs. It has well demonstrated reliability
and validity in cancer populations.31
Secondary outcomes
Positive adjustment: Positive adjustment was measured
with a 21-item Post-traumatic Growth Inventory assessing
perceived positive life change occurring after a diagnosis
of cancer.32 Domains assessed include strengthened relationships, appreciation of life, personal strength, new
priorities and spiritual/religious growth. Higher scores
indicate greater positive life changes. This scale is widely
used in cancer populations.33
QoL and health economics: The Assessment of Quality
of Life-8D (AQoL-8D)34 is a 35-item scale assessing QoL
on eight dimensions including: independent living, relationships, mental health, self-worth, happiness, coping,
pain and sensory perception, and allows a simple global
utility score to be calculated. Higher scores indicate
better functioning and QoL. The AQoL-8D is the primary
outcome instrument for the economic appraisal, has
excellent psychometric properties and has been used
in over 80 trials in Australia. We also obtain self-report
data about visits to primary healthcare providers (general
practitioners (GPs), psychologists) and use of prescription medications on the Pharmaceutical Benefits Scheme
at baseline and at 12-month follow-up. These data will be
used in an alongside trial cost–utility analysis of the trial.
Process variables
Participants in the CancerCope arm complete three
process measures at the end of the intervention (2
months) and again at the end of follow-up (12 months).
Internet evaluation and utility questionnaire: assesses
patients’ experiences and perceptions of an internet
intervention.35 36 This measure includes ease of use,
convenience, engagement, enjoyment, layout, privacy,
satisfaction and acceptability, and perceptions of the web
programme material in terms of usefulness, comprehension, credibility, likelihood of returning, mode of delivery
and helpfulness.
Internet intervention adherence questionnaire: identifies obstacles and barriers that interfere with using
internet intervention programmes.35 37
Internet impact and effectiveness questionnaire:
assesses patients’ perceptions of the internet intervention in terms of the programme’s effectiveness in
resolving their targeted health condition. Perceived
impact is measured in terms of helpfulness, knowledge gains, treatment effectiveness for self, treatment
6

effectiveness for others, long-term effectiveness, QoL,
mood, physical activity, family relationships, peer relationships, social activity, school/work attendance,
school/work performance, treatment implementation,
goal orientation, confidence in ability to manage the
health condition, relapse prevention and service reduction.35 36
Statistical analyses
The study is a multivariate, two-condition RCT with
repeated measures across time. We will examine this
design using a multilevel model in which measurement
occasions (level 1) are nested within persons (level 2)
and in which programme differences are represented
as a fixed effect at level 2 whose interaction with time
represents differential adjustment and distress trajectories for the two groups. This approach to longitudinal
designs is widely applied to contemporary intervention
research. A key advantage of this approach is flexibility
in dealing with missing data owing either to random or
non-random attrition. Further, subgroups of patients who
respond differentially to the programme will be identified using growth mixture modelling that is a related
longitudinal procedure that identifies cases with similar
distress and adjustment trajectories across time.38
A post hoc power calculation based on 79 people in the
CancerCope Intervention and 84 in the Patient Education arm (163 in total) means that our study cohort will
provide 89% power to detect a medium effect size (0.5)
with a significance level (alpha) of 0.05 using a two-sided
two-sample t-test.
The cost–utility analysis will be undertaken from the
perspective of costs to the health system for primary
healthcare associated with psychological distress.
Resource use, such as GP, specialist and psychology
visits, will be multiplied by the unit costs for those
services. The average cost per patient per month
for each class of pharmaceutical will be included,
along with the cost of the intervention. Costs will be
summed for the intervention and the control groups.
The AQoL-8D will be scored with the Australian value
set and QALYs estimated as the area under the curve.
The costs and QALYs in the intervention and control
groups will be compared and the additional cost per
QALY gained estimated. Sensitivity analysis, and where
feasible subgroup analyses, will be undertaken to identify key parameters and populations with the greatest
effect on results.
Ethics and dissemination
Ethics
Ethical approval was obtained from the Griffith University Human Research Ethics Committee (approval:
PSY/70/13/HREC) and the Metro South Human
Research Ethics Committee (HREC/13/QPAH/601).
All participants provide informed consent prior to taking
part in the study.
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Table 2 Sample sociodemographic characteristics
and self-reported cancer history and support access for
participants in phase II (n=163)

Table 2

Variable

n (%)

Access psychological care (yes)*

20 (12)

Sex
 Male

 Psychiatrist

5 (3)

52 (32)

 Psychologist

15 (9)

 Female

111 (68)

 Counsellor

4 (2)

Age group at diagnosis (years)
 18–49

43 (26)

 50–69

91 (56)

 70+

29 (18)

Mean age (years)

57.3

Partner
 Yes

123 (75)

 No

40 (25)

Education

Continued

Variable

n (%)

Access support (yes)
  Doctor

118 (72)

 Social worker

20 (12)

 Nurse/other health professionals

73 (45)

  Family/friends

143 (88)

  Internet

87 (53)

  Library

4 (2)

 Books/brochures from doctor

85 (52)

 Books/brochures from family

18 (11)

 Cancer Helpline

81 (50)

 Support group

15 (9)

 CCQ counselling service

17 (10)
4 (2)
49 (30)

 University

44 (27)

 Trade/certificate

56 (34)

 Senior high

17 (10)

 Less than senior

46 (28)

 Other counselling service
 Other support

 Employed

56 (34)

 Retired

46 (28)

*People can access more than one psychological care service.
CCQ, Cancer Council Queensland.

 Other

61 (38)

Employment

Patients
Recruitment for phase II commenced through the
QCR in April 2015 and through the Cancer Helpline
in November 2015, and was completed in May 2016
with follow-up ongoing. A total of 163 participants were
recruited into the study. For QCR recruitment, once
eligibility was confirmed, 87.2% agreed to participate.
Of those eligible patients identified through the Cancer
Helpline, 58.3% agreed to participate.
The main reasons for ineligibility were: participants
not being distressed, no access to internet/computer
and metastatic or recurrent disease. For example, over
58% of participants who provided consent through the
QCR recorded a distress level of less than 4 on the DT.9
Main reasons for refusal included: no time to participate,

Income
 <$40 000

52 (32)

 $40 000–80 000

46 (28)

 $80 000–130 000

32 (20)

 $130 000+

24 (15)

 Not answered

9 (5)

Cancer type
 Colorectal

60 (37)

 Breast

42 (26)

 Melanoma

29 (18)

 Other

32 (19)

Time to recruitment after diagnosis
 0–3 months

48 (29)

 4–6 months

58 (36)

 6–12 months

38 (23)

 More than 12 months

19 (12)

 Median time (days)

139

Table 3 Unmet supportive care needs for participants in
phase II (n=163)

Need domain

Treatment type
  Had surgery

139 (85)

  Had chemotherapy

68 (42)

  Had radiation therapy

20 (12)

  Had hormone therapy
  Had other treatment

1 (1)
17 (10)
Continued

Chambers SK, et al. BMJ Open 2017;7:e017279. doi:10.1136/bmjopen-2017-017279

% reporting low, % reporting
moderate or high moderate or high
need
need

Physical and daily
living
Psychological

77.9

55.2

88.3

74.2

Patient care/support

40.5

24.5

Sexuality
Health system/
information

36.2
54.0

23.3
41.7
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Table 4 Top 10 unmet supportive care needs by low, moderate or high need and moderate or high for participants in phase II
(n=163)
Need item

% reporting low, moderate
or high need
Need domain

Low, moderate or high need
 Uncertainty about the future

71.2

Psychological

 Concerns about the worries of those close to you

67.5

Psychological

 Fears about the cancer spreading

66.3

Psychological

 Worry that the results of treatment are beyond your control

64.4

Psychological

 Learning to feel in control of your situation

59.5

Psychological

 Lack of energy/tiredness

57.7

Physical and daily living

 Not being able to do the things you used to do

56.4

Physical and daily living

 Feeling down or depressed

55.8

Psychological

 Feelings of sadness

54.0

Psychological

 Anxiety

53.4

Psychological

Moderate or high need
 Uncertainty about the future

49.7

Psychological

 Fears about the cancer spreading

44.8

Psychological

 Concerns about the worries of those close to you

44.2

Psychological

 Worry that the results of treatment are beyond your control

42.3

Psychological

 Lack of energy/tiredness

37.4

Physical and daily living

 Not being able to do the things you used to do

35.0

Physical and daily living

 Work around the home

33.7

Physical and daily living

 Learning to feel in control of your situation

31.9

Psychological

 Anxiety
 Feelings of sadness

29.5
28.8

Psychological
Psychological

participation impaired by illness or treatment, preferred
alternative support (eg, face-to-face counselling rather
than computer-based support), already had enough
support from health professionals and/or friends and
family, did not need support and not interested after
receiving further information.
Background and support use
The sociodemographic characteristics, cancer history
and support use of participants at baseline are reported
in table 2. The median time since diagnosis at baseline
was 139 days. Twelve per cent were currently receiving
specialised psychological care. Since their cancer diagnosis, 88% of participants reported receiving support
from family and friends, 72% from a doctor, 53% from
the internet, 52% from books or brochures from a doctor,
50% from the Cancer Helpline and 45% from a nurse or
other health professionals.
Psychological distress
A total of 50.3% participants met caseness on the BSI 18
for clinically significant psychological distress (as indicated by a score of ≥57 for either total GSI t-score or two
subscale t-scores).25The mean scores for each dimension
in the BSI 18 were 4.7 (SD=4.0) for somatisation, 4.4
8

(SD=4.2) for anxiety and 4.0 (SD=4.5) for depression,
with a mean GSI score of 13.1 (SD=10.8).
Supportive care needs
Table 3 provides descriptive statistics for the supportive
care needs domains. A high proportion (88.3%) of participants reported some unmet need (low, moderate or
high) in the psychological domain, with 74.2% reporting
moderate or high need in this domain. This was followed
by physical and daily living (77.9% and 55.2%), health
system/information (54.0% and 41.7%), patient care/
support (40.5% and 24.5%) and sexuality (36.2% and
23.3%) domains. The top 10 unmet needs are listed in
table 4 for low, moderate or high need and moderate or
high need, with the majority of these in the psychological
domain.
Discussion
As in previous studies,14 39 the area of greatest unmet need
in this cohort of patients with cancer was in the psychological domain and, in particular, fears about cancer
recurrence. Needs around feeling depressed or anxious,
tiredness, loss of control and concerns about family were
also highly prevalent. This may be expected in a patient
Chambers SK, et al. BMJ Open 2017;7:e017279. doi:10.1136/bmjopen-2017-017279
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population that have been screen detected as distressed
(although only 50% reached caseness on retesting).
However, we note that of these patients, only 12% were
receiving specialised psychological care on study entry.
We propose that this emphasises the point that many
distressed cancer patient do not seek or receive professional psychological care within the current cancer care
system,40 and that accessible care models are urgently
needed.41 42 Moreover, this need will only increase as the
cancer burden escalates in the future.43 44
Once completed, this trial will provide recommendations about the efficacy of web-based cognitive
behavioural interventions to facilitate better psychosocial
adjustment and mental health for people with cancer. We
note that recruitment rates were much lower for Cancer
Helpline callers compared with those approached from
the cancer registry. This suggests that Helpline callers
who have already accessed telephone-based support may
feel their support needs to be met or may be disinclined
to use an alternative remote access service. However, the
high recruitment rate for patients from the QCR suggests
the web-based approach is acceptable for patients who
are not already linked in to community-based support
services. To our knowledge, there is no readily available
online psychological intervention that directly targets the
needs of distressed patients with cancer in the Australian
setting. The project will provide an evidence-based, practical and applied approach to psychological intervention
for people with cancer that can be rapidly translated into
the population, and improve health outcomes by delivering an ‘on demand’ web-based psychological therapy
service targeted to the needs of this group.
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